Neuroligin 1—A New Substrate for γ-Secretase
These ideas will be discussed in the Alzforum Webinar.—Esther Landhuis None
379 RESULTS
You searched Esther
Sort By:
These ideas will be discussed in the Alzforum Webinar.—Esther Landhuis None
ensure that clinical trials adhere to global standards of scientific rigor and ethical behavior.—Esther
a study of AD genetics.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2827
premature aging.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3023 Aging Research Models
more mechanistic work and trying to design analogs, Barnham said.—Esther Landhuis None
of fragile X syndrome, the most common genetic cause of autism (Jung et al., 2012).—Esther Landhuis
people with neuropathic pain (Boccard et al., 2013).—Esther Landhuis None
levels of inhibition.—Esther Landhuis. This is Part 2 of a three-part series. See also Part 1, Part 3.
Eisai’s oral gamma-secretase modulator (E2212) in healthy adults.—Esther Landhuis None
LilrB2 sits near apolipoprotein E (the top AD risk gene) on chromosome 19.—Esther Landhuis None
investigate the mechanisms for generation of the N-terminal fragments and their potential functions.—Esther
between 2000 and 2002 from ESTHER, a population-based longitudinal cohort of nearly 10,000 healthy older
related news story on Galasko et al., 2010).—Esther Landhuis None
Aβ,” Ashe said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3427 Alzheimer's
option.—Esther Landhuis. This is Part 1 of a two-part series. See Part 2 Q&A With Sue Anderson, FDA